Skip to main content

Table 2 Clinical data of tumors

From: Surgical outcomes of one-stage resection for synchronous multiple primary lung adenocarcinomas with no less than three lesions

Variables

Number(%)

Mean value

Total number of tumors

95

 

Tumor characteristics (mm)

  

 pGGO

43 (45.3)

9.60 ± 4.23

 mGGO

39 (41.1)

16.37 ± 6.35

 SN

13 (13.6)

24.01 ± 11.67

Tumor type pattern per patient

  

 Multiple pGGO

5 (17.9)

 

 Multiple mGGO

3 (10.7)

 

 pGGO + mGGO

13 (46.4)

 

 SN + GGO

4 (14.3)

 

 Multiple SN

3 (13.7)

 

Location of tumors

  

 RUL

44 (46.3)

 

 RML

14 (14.7)

 

 RLL

12 (12.6)

 

 LUL

17 (17.9)

 

 LLL

8 (8.5)

 

Location of lobe

  

 Same lobe

6 (21.4)

 

 Different lobe

2 (7.1)

 

 Combined lobea

20 (71.5)

 

Size of tumors (mm)

 

15.89 ± 8.97

 ≤ 10 mm

52 (54.7)

 

 < 10 mm,  ≤ 20 mm

32 (33.7)

 

 > 20 mm

11 (11.6)

 

Histology in all tumors

  

 AIS

27 (28.4)

 

 MIA

17 (17.9)

 

 IA (WD/MD/PD)

51 (9/36/6)(53.7)

 

EGFR in tumors per patient

  

 WT

6 (21.4)

 

 Mutation

22 (72.6)

 
  1. SN, solid nodule; pGGO, pure ground-glass opacity; mGGO, mixed ground-glass opacity;
  2. RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, Left lower lobe; aMore than 2 cancers, at least 2 tumors were located at the same lobe and the other or others located at the different; AAH, atypical adenocarcinoma hyperplasia; AIS, adenocarcinoma in situ; MIA, minimally invasive adenocarcinoma; IA, invasive adenocarcinoma; WD, well-differentiated; MD, moderately-differentiated; PD, poorly differentiated